SOD1 and amyotrophic lateral sclerosis: ALS mice treated with this approach by intrathecal delivery had a reduced rate of muscle atrophy, decreased muscle denervation, improved neuromuscular function and up to 40% fewer superoxide dismutase 1 (SOD1) immunoreactive inclusions [155].